医師が調剤する化粧品の市場規模、シェア、成長分析：タイプ別、用途別、地域別 - 産業予測 2025～2032年

医師が調剤する化粧品の世界市場規模は、2023年に281億6,000万米ドルと評価され、2024年の303億6,000万米ドルから2032年には553億6,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは7.8％で成長する見通しです。

皮膚科医や美容外科医を含む医療専門家によって処方される専用製品である医師が調剤する化粧品市場は、美容とアンチエイジング・ソリューションに対する消費者の関心の高まりに牽引され、大きく成長する見通しです。こうした製品の安全性と有効性に対する認識が高まるにつれ、シミやニキビなど特定の肌問題に的を絞った治療を求める消費者が増えています。この需要は、皮膚の表面下で目に見える生物学的効果を提供する、医学的指導に基づく介入への嗜好の変化により、さらに拍車がかかっています。しかし、厳しい政府規制、激しい市場競争、代替治療の増加といった課題が、予測期間におけるこの分野の成長の障害となる可能性があります。全体として、医師が調剤する化粧品市場は、今後ダイナミックな変化を経験することになると思われます。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 顧客と購買基準の分析
• 貿易分析
• 原材料の分析

医師が調剤する化粧品市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• スキンケア
  • アンチエイジング
  • 日焼け止め
  • その他のスキンケア製品
• アイケア
  • 目薬
  • その他のアイケア製品
• ヘアケア
  • ヘアリペア
  • フケ防止
  • その他のヘアケア製品
• その他のタイプ

医師が調剤する化粧品市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 病院薬局
• 小売薬局
• オンライン販売

医師が調剤する化粧品市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Allergan Plc（AbbVie Inc.）（USA）
• L'Oreal S.A.（France）
• Jan Marini Skin Research, Inc.（USA）
• Athena Cosmetics, Inc.（USA）
• ZO Skin Health Inc.（USA）
• Galderma Laboratories, L.P.（Switzerland）
• Procter & Gamble Co.（USA）
• The Estee Lauder Companies, Inc.（USA）
• Merz Pharma GmbH & Co. KGaA（Germany）
• Obagi Cosmeceuticals LLC（USA）
• iS CLINICAL（Innovative Skincare）（USA）
• Neutrogena Corporation（USA）
• Velius, LLC（USA）
• Sonoma Pharmaceuticals, Inc.（USA）
• Sientra, Inc.（USA）
• Dynamic Techno Medicals（India）
• Implantech Associates, Inc.（USA）
• CCA Industries, Inc.（USA）
• SkinMedica, Inc.（USA）
• Biopelle, Inc.（USA）

結論と推奨事項

Global Physician Dispensed Cosmeceuticals Market size was valued at USD 28.16 billion in 2023 and is poised to grow from USD 30.36 billion in 2024 to USD 55.36 billion by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032).

The market for physician-dispensed cosmeceuticals, exclusive products prescribed by medical professionals including dermatologists and cosmetic surgeons, is poised for significant growth driven by increasing consumer interest in beauty and anti-aging solutions. As awareness about the safety and efficacy of these products rises, more consumers are seeking targeted treatments for specific skin issues, such as age spots and acne. This demand is further fueled by the shifting preference toward medically guided interventions that offer tangible biological effects beneath the skin's surface. However, challenges such as stringent government regulations, intense market competition, and the growing availability of alternative treatments may pose obstacles to growth in this sector over the forecast period. Overall, the physician-dispensed cosmeceuticals market is set to experience dynamic changes ahead.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Physician Dispensed Cosmeceuticals market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Physician Dispensed Cosmeceuticals Market Segmental Analysis

Global Physician Dispensed Cosmeceuticals Market is segmented by Type, Application and region. Based on Type, the market is segmented intoSkin Care, Eye Care, Hair Care and Other Types. Based on Application, the market is segmented into Hospital Pharmacy, Retail Pharmacy and Online Sales. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Physician Dispensed Cosmeceuticals Market

The global market for physician-dispensed cosmeceuticals is significantly influenced by an increasing awareness of personal grooming and maintenance, particularly among the elderly and middle-aged populations in emerging markets. As attitudes shift, more individuals acknowledge the importance of cosmeceuticals in addressing visible signs of aging. Additionally, a growing number of upper- and middle-class consumers, both men and women in developed countries, are becoming more informed about these products, further fueling market expansion. In low-income regions, rising levels of women's education have improved access to print media, journals, and advertisements, providing critical information that helps consumers evaluate authentic and effective cosmeceuticals.

Restraints in the Global Physician Dispensed Cosmeceuticals Market

A significant restraint in the Global Physician Dispensed Cosmeceuticals market is the limited awareness among consumers, particularly in underdeveloped and impoverished nations, regarding contemporary and innovative cosmeceutical products. Many individuals in these regions are unfamiliar with the benefits and outcomes associated with these offerings, which in turn diminishes their interest in utilizing such products. Additionally, the high costs associated with medical consultations and cosmeceuticals further compound this issue, discouraging potential users from seeking out and incorporating cosmeceuticals into their skincare routines. Thus, the lack of knowledge significantly hampers market growth in these areas.

Market Trends of the Global Physician Dispensed Cosmeceuticals Market

The Global Physician Dispensed Cosmeceuticals market is witnessing a significant upward trend, driven by the increasing consumer demand for advanced skincare solutions that blend cosmetic benefits with therapeutic efficacy. Innovations such as SkinCeuticals' Vivace Fractional Micro Needle Radio Frequency Procedure, which combines cutting-edge technology with high-quality active ingredients like C E Ferulic, are setting new standards in skin rejuvenation treatments. This trend reflects a growing consumer preference for physician-backed products, emphasizing safety and effectiveness. As awareness around skin health continues to rise, the market is poised for robust growth, fostering the development of more sophisticated, minimally invasive procedures that cater to diverse skincare needs.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Customer & Buying Criteria Analysis
• Trade Analysis
• Raw Material Analysis

Global Physician Dispensed Cosmeceuticals Market Size by Type & CAGR (2025-2032)

• Market Overview
• Skin Care
  • Anti-Ageing
  • Sunscreens
  • Other Skin Care Products
• Eye Care
  • Eye Drops
  • Other Eye Care Products
• Hair Care
  • Hair Repair
  • Anti-dandruff
  • Other Hair Care Products
• Other Types

Global Physician Dispensed Cosmeceuticals Market Size by Application & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacy
• Retail Pharmacy
• Online Sales

Global Physician Dispensed Cosmeceuticals Market Size & CAGR (2025-2032)

• North America (Type, Application)
  • US
  • Canada
• Europe (Type, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Allergan Plc (AbbVie Inc.) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• L'Oreal S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jan Marini Skin Research, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Athena Cosmetics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZO Skin Health Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Galderma Laboratories, L.P. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Procter & Gamble Co. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Estee Lauder Companies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merz Pharma GmbH & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Obagi Cosmeceuticals LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• iS CLINICAL (Innovative Skincare) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neutrogena Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Velius, LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sonoma Pharmaceuticals, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sientra, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dynamic Techno Medicals (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Implantech Associates, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CCA Industries, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SkinMedica, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biopelle, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations